Recital 25, Regulation (EU) 2024/2865

In forcesince 23 Oct 2024

As the criteria for substances to qualify as an endocrine disruptor for human health or the environment included in sections 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009 of the European Parliament and of the Council [Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1).] and in Commission Delegated Regulation (EU) 2017/2100 [Commission Delegated Regulation (EU) 2017/2100 of 4 September 2017 setting out scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU) No 528/2012 of the European Parliament and Council (OJ L 301, 17.11.2017, p. 1).], and those to qualify as an endocrine disruptor for human health or the environment included in Annex I to Regulation (EC) No 1272/2008, are equivalent, substances which qualify as meeting the criteria for endocrine disruptor properties in accordance with Commission Regulation (EU) 2018/605 [Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine-disrupting properties (OJ L 101, 20.4.2018, p. 33).] and Delegated Regulation (EU) 2017/2100 should be included in ‘endocrine disruption for human health category 1’ or ‘endocrine disruption for the environment category 1’ in Table 3 in Part 3 of Annex VI to Regulation (EC) No 1272/2008.